Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves

Journal of Thoracic and Cardiovascular Surgery

Volumn 131, Issue 6, 2006, Pages 1323-1330

  Stock, U A ^a,b,c   Degenkolbe, I ^a,b   Attmann, T ^d   Schenke Layland, K ^e   Freitag, S ^d   Lutter, G ^d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Heart Center Brandenburg   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CAROTID ARTERY; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HEART VALVE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; SUBMUCOSA; TISSUE ENGINEERING; TISSUE INJURY;

ANIMALS; BIOPROSTHESIS; CELLS, CULTURED; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; PULMONARY VALVE; STENTS; TISSUE ENGINEERING;

EID: 33646843090     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.01.053     Document Type: Article

References (21)

1. de Ruijter F.T., Weenink I., Hitchcock F.J., Meijboom E.J., and Bennink G.B. Right ventricular dysfunction and pulmonary valve replacement after correction of tetralogy of Fallot. Ann Thorac Surg 73 (2002) 1794-1800
2. Coats L., Tsang V., Khambadkone S., van Doorn C., et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg 27 (2005) 536-543
3. Nerem R.M. Cellular engineering. Ann Biomed Eng 19 (1991) 529-545
4. Schenke-Layland K., Opitz F., Gross M., et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Cardiovasc Res 60 (2003) 497-509
5. Hodde J.P., Record R.D., Tullius R.S., and Badylak S.F. Retention of endothelial cell adherence to porcine-derived extracellular matrix after disinfection and sterilization. Tissue Eng 8 (2002) 225-234
6. Shell IV D.H., Croce M.A., Cagiannos C., et al. Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of gram-positive contamination. Ann Surg 241 (2005) 995-1001
7. White J.K., Agnihotri A.K., Titus J.S., and Torchiana D.F. A stentless trileaflet valve from a sheet of decellularized porcine small intestinal submucosa. Ann Thorac Surg 80 (2005) 704-707
8. Stock U.A., Wiederschain D., Kilroy S.M., et al. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem 81 (2001) 220-228
9. Schenke-Layland K., Riemann I., Opitz F., et al. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 23 (2004) 113-125
10. Schenke-Layland K., Vasilevski O., Opitz F., et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 143 (2003) 201-208
11. Frigiola A., Redington A.N., Cullen S., and Vogel M. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 110 suppl (2004) II153-II157
12. Mayer Jr. J.E. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin Thorac Cardiovasc Surg 7 (1995) 130-132
13. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Transcatheter implantation of a bovine valve in pulmonary position. Circulation 102 (2000) 813-816
14. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356 (2000) 1403-1405
15. Ruiz C.E., Iemura M., Medie S., et al. Transcatheter placement of a low-profile biodegradable pulmonary valve made of small intestinal submucosa. a long-term study in a swine model. J Thorac Cardiovasc Surg 130 (2005) 477-484
16. Stock U.A., and Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 27 (2006) 1-2
17. Simon P., Kasimir M.T., Seebacher G., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23 (2003) 1002-1006
18. Goldstein S., Clarke D.R., Walsh S.P., et al. transpecies heart valve transplant. advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 70 (2000) 1962-1969
19. Migliavacca F., Schievano S., Dubini G., et al. Percutaneous valve replacement. an engineer's perspective (2004) Presented at: Advances in Tissue Engineering and Biology of Heart Valves Meeting; Florence, Italy; Sept 15-18
20. Lutter G., Kuklinski D., Berg G., et al. Percutaneous aortic valve replacement. an experimental study. I. studies on implantation. J Thorac Cardiovasc Surg 123 (2002) 768-776
21. Rieder E., Seebacher G., Kasimir M.T., et al. Tissue engineering of heart valves. decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111 (2005) 2792-2797